- Home
- RAYA vs SPRB Comparison
RAYA vs SPRB Comparison
Compare RAYA & SPRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- SPRB
- Stock Information
- Founded
- RAYA 2019
- SPRB 2014
- Country
- RAYA China
- SPRB United States
- Employees
- RAYA N/A
- SPRB N/A
- Industry
- RAYA Metal Fabrications
- SPRB Medicinal Chemicals and Botanical Products
- Sector
- RAYA Consumer Discretionary
- SPRB Health Care
- Exchange
- RAYA Nasdaq
- SPRB Nasdaq
- Market Cap
- RAYA N/A
- SPRB 17.6M
- IPO Year
- RAYA 2022
- SPRB 2020
- Fundamental
- Price
- RAYA $1.10
- SPRB $0.51
- Analyst Decision
- RAYA
- SPRB Hold
- Analyst Count
- RAYA 0
- SPRB 7
- Target Price
- RAYA N/A
- SPRB $2.50
- AVG Volume (30 Days)
- RAYA 81.6K
- SPRB 514.6K
- Earning Date
- RAYA 07-09-2024
- SPRB 11-11-2024
- Dividend Yield
- RAYA N/A
- SPRB N/A
- EPS Growth
- RAYA N/A
- SPRB N/A
- EPS
- RAYA 0.10
- SPRB N/A
- Revenue
- RAYA $20,322,498.00
- SPRB $9,572,000.00
- Revenue This Year
- RAYA $64.53
- SPRB N/A
- Revenue Next Year
- RAYA $9.61
- SPRB N/A
- P/E Ratio
- RAYA $10.24
- SPRB N/A
- Revenue Growth
- RAYA N/A
- SPRB 131.82
- 52 Week Low
- RAYA $0.44
- SPRB $0.41
- 52 Week High
- RAYA $1.65
- SPRB $5.95
- Technical
- Relative Strength Index (RSI)
- RAYA 68.80
- SPRB 63.42
- Support Level
- RAYA $0.71
- SPRB $0.43
- Resistance Level
- RAYA $1.30
- SPRB $0.54
- Average True Range (ATR)
- RAYA 0.15
- SPRB 0.03
- MACD
- RAYA 0.04
- SPRB 0.01
- Stochastic Oscillator
- RAYA 71.01
- SPRB 72.03
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).